Hansoh Pharma Strikes Roche Drug Deal Worth Over $15 Billion
Hansoh Pharmaceutical said its units entered a collaboration and licensing deal with Roche covering antibody-drug conjugate programs. The deal is potentially worth more than $15 billion.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.